REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12) After 12 weeks off therapy (week 25 of the study), 82% of evaluable patients (9 of 11) maintained a durable reduction in total polyp burden, […]
Read More »Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober
Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober VICTORIA, Seychelles, Dec. 08, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), today released its October 2025 Protection Fund report, recording an average monthly valuation of $741,435,710 despite a challenging month across digital asset markets. The fund peaked at $811,031,000 on October […]
Read More »EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025
Recognition follows a vote by professional and active traders, highlighting the critical role of execution quality in institutional-grade trading Best Broker for Execution at the Professional Trader Awards 2025 – EBC Financial Group LONDON, Dec. 08, 2025 (GLOBE NEWSWIRE) — EBC Financial Group (“EBC”) has been named Best Broker for Execution at the Professional Trader Awards 2025, […]
Read More »Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows
LONDON, Dec. 08, 2025 (GLOBE NEWSWIRE) — A sharp acceleration in global wealth migration in 2025 is colliding with rapidly diverging private healthcare costs worldwide, making the availability and costs of reliable private care a decisive factor in where high-net-worth families choose to live, invest, and secure residence or citizenship rights. New client data released […]
Read More »Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting
DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time […]
Read More »Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users
Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users VICTORIA, Seychelles, Dec. 05, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), today announced a major upgrade to GetAgent, its AI-powered trading assistant. The update introduces a more flexible answering engine, a streamlined user interface, and a […]
Read More »Moonup Technology Partners with European Smart Home Leader Shelly to Showcase Full Smart Building Ecosystem at the 2025 Taipei Building Show
Moonup Technology CEO Aaron Hsu TAIPEI, Taiwan, Dec. 04, 2025 (GLOBE NEWSWIRE) — Moonup Technology Co., Ltd., the Taiwan operations partner of European smart home leader Shelly (Shelly Group), announced its major participation in the 2025 Taipei Building Show to be held from December 11 to December 14 at Nangang Exhibition Center. The company will […]
Read More »
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service